Medical Editor: John P. Cunha, DO, FACOEP
Alamast (pemirolast potassium) ophthalmic solution is a mast cell stabilizer, which is an anti-allergic medication, used to treat ocular (eye) symptoms of allergic conditions, such as itching. Common side effects of Alamast include headache, runny or stuffy nose, sneezing, eye burning or discomfort, itchy eyes, feeling as if something is in your eye, dry eyes, other eye discomfort, allergic reactions (rash, hives, itching), back pain, difficulty breathing, or fever.
The recommended dose of Alamast is one to two drops in each affected eye four times daily. Do not use other eye medications during treatment with Alamast ophthalmic unless directed by your doctor. Other drugs may interact with Alamast ophthalmic. Tell your doctor all prescription or over-the-counter medicines and supplements you use. During pregnancy, Alamast should be used only when prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Alamast (pemirolast potassium) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Alamast (Pemirolast Potassium Ophthalmic Solution)
In clinical studies lasting up to 17 weeks with ALAMAST® (pemirolast potassium ophthalmic solution) ophthalmic solution, headache, rhinitis, and cold/flu symptoms were reported at an incidence of 10–25%. The occurrence of these side effects was generally mild. Some of these events were similar to the underlying ocular disease being studied.
The following ocular and non-ocular adverse reactions were reported at an incidence of less than 5%:
Ocular: burning, dry eye, foreign body sensation, and ocular discomfort.
Read the entire FDA prescribing information for Alamast (Pemirolast Potassium Ophthalmic Solution)